These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 7757973

  • 1. Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL.
    Schwarze MM, Hawley RG.
    Cancer Res; 1995 Jun 01; 55(11):2262-5. PubMed ID: 7757973
    [Abstract] [Full Text] [Related]

  • 2. Role of bcl-X(L) in the control of apoptosis in murine myeloma cells.
    Gauthier ER, Piché L, Lemieux G, Lemieux R.
    Cancer Res; 1996 Mar 15; 56(6):1451-6. PubMed ID: 8640839
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression.
    Akbar AN, Borthwick NJ, Wickremasinghe RG, Panayoitidis P, Pilling D, Bofill M, Krajewski S, Reed JC, Salmon M.
    Eur J Immunol; 1996 Feb 15; 26(2):294-9. PubMed ID: 8617294
    [Abstract] [Full Text] [Related]

  • 4. Regulation of bcl-2, bcl-XL and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone.
    Lotem J, Sachs L.
    Cell Growth Differ; 1995 Jun 15; 6(6):647-53. PubMed ID: 7669718
    [Abstract] [Full Text] [Related]

  • 5. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.
    Jourdan M, De Vos J, Mechti N, Klein B.
    Cell Death Differ; 2000 Dec 15; 7(12):1244-52. PubMed ID: 11175262
    [Abstract] [Full Text] [Related]

  • 6. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death.
    Boussiotis VA, Lee BJ, Freeman GJ, Gribben JG, Nadler LM.
    J Immunol; 1997 Oct 01; 159(7):3156-67. PubMed ID: 9317113
    [Abstract] [Full Text] [Related]

  • 7. Bcl-xS and Bax induce different apoptotic pathways in PC12 cells.
    Lindenboim L, Yuan J, Stein R.
    Oncogene; 2000 Mar 30; 19(14):1783-93. PubMed ID: 10777212
    [Abstract] [Full Text] [Related]

  • 8. IFN-gamma upregulates anti-apoptotic gene expression and inhibits apoptosis in IL-3-dependent hematopoietic cells.
    Sekiya M, Adachi M, Takayama S, Reed JC, Imai K.
    Biochem Biophys Res Commun; 1997 Oct 20; 239(2):401-6. PubMed ID: 9344841
    [Abstract] [Full Text] [Related]

  • 9. The apoptosis and proliferation of SAC-activated B cells by IL-10 are associated with changes in Bcl-2, Bcl-xL, and Mcl-1 expression.
    Li L, Krajewski S, Reed JC, Choi YS.
    Cell Immunol; 1997 May 25; 178(1):33-41. PubMed ID: 9184696
    [Abstract] [Full Text] [Related]

  • 10. The survival of IL-6-dependent myeloma cells critically relies on their capability to transit the G1 to S phase interval of the cell cycle.
    Côté S, Lemieux R, Simard C.
    Cell Signal; 2005 May 25; 17(5):615-24. PubMed ID: 15683736
    [Abstract] [Full Text] [Related]

  • 11. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells.
    Walker A, Taylor ST, Hickman JA, Dive C.
    Cancer Res; 1997 May 15; 57(10):1939-45. PubMed ID: 9157989
    [Abstract] [Full Text] [Related]

  • 12. v-Abl protein tyrosine kinase (PTK) mediated suppression of apoptosis is associated with the up-regulation of Bcl-XL.
    Chen Q, Turner J, Watson AJ, Dive C.
    Oncogene; 1997 Oct 15; 15(18):2249-54. PubMed ID: 9393984
    [Abstract] [Full Text] [Related]

  • 13. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity.
    Moreno MB, Memon SA, Zacharchuk CM.
    J Immunol; 1996 Nov 01; 157(9):3845-9. PubMed ID: 8892614
    [Abstract] [Full Text] [Related]

  • 14. Relative level of expression of Bax and Bcl-XL determines the cellular fate of apoptosis/necrosis induced by the overexpression of Bax.
    Shinoura N, Yoshida Y, Asai A, Kirino T, Hamada H.
    Oncogene; 1999 Oct 07; 18(41):5703-13. PubMed ID: 10523849
    [Abstract] [Full Text] [Related]

  • 15. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM, Turchi JJ.
    Cancer Res; 1999 Jul 01; 59(13):3077-83. PubMed ID: 10397248
    [Abstract] [Full Text] [Related]

  • 16. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.
    Nuñez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ.
    J Immunol; 1990 May 01; 144(9):3602-10. PubMed ID: 2184193
    [Abstract] [Full Text] [Related]

  • 17. Role of Bax in apoptosis of IL-3-dependent cells.
    Low W, Olmos-Centenera G, Madsen C, Leverrier Y, Collins MK.
    Oncogene; 2001 Jul 27; 20(33):4476-83. PubMed ID: 11494143
    [Abstract] [Full Text] [Related]

  • 18. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
    Sawada M, Nakashima S, Banno Y, Yamakawa H, Takenaka K, Shinoda J, Nishimura Y, Sakai N, Nozawa Y.
    Oncogene; 2000 Jul 20; 19(31):3508-20. PubMed ID: 10918609
    [Abstract] [Full Text] [Related]

  • 19. Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis.
    Hinz S, Trauzold A, Boenicke L, Sandberg C, Beckmann S, Bayer E, Walczak H, Kalthoff H, Ungefroren H.
    Oncogene; 2000 Nov 16; 19(48):5477-86. PubMed ID: 11114725
    [Abstract] [Full Text] [Related]

  • 20. Mcl-1 mediates cytokine deprivation induced apoptosis of human myeloma cell line XG-7.
    Song L, Li Y, Sun Y, Shen B.
    Chin Med J (Engl); 2002 Aug 16; 115(8):1241-3. PubMed ID: 12215301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.